Effectiveness of a patient-specific 3-dimensional printed model in Septal Myectomy of hypertrophic cardiomyopathy
- PMID: 33235596
- PMCID: PMC7674891
- DOI: 10.12669/pjms.36.7.2620
Effectiveness of a patient-specific 3-dimensional printed model in Septal Myectomy of hypertrophic cardiomyopathy
Abstract
Objective: Advanced cardiovascular surgery in structural heart disease require accurate pre-operative evaluation. Most of non-invasive imaging technologies remain limited in two-dimensional and show insufficiency of visualization for procedural planning. The aim of this study was to discuss the value of patient-specific 3-dimensional (3D) printing in treatment of hypertrophic cardiomyopathy (HCM).
Methods: Patient-specific 3D-printed models were constructed preoperatively in 12 consecutive HOCM patients which come to Beijing Anzhen Hospital for surgical treatment from October 2016 to March 2017. Image files were extracted from multi-slice computed tomography images, 3D models were constructed by the Mimics 19.0 software and generated by Objet350 Connex3 3D printer. The 3D-printed models were made with soft material that can be surgically performed. The modified Morrow myectomy of the model was performed before the operation. Clinical characters and echocardiographic parameters were recorded.
Results: There was no significant difference in tissue volume between the models and specimens. Preoperative and postoperative echocardiography showed the septal thickness was reduced from 18.8±4.5 mm to 12.7±3.3 mm (p<0.001), the left ventricular outflow tract obstruction was adequately relieved (83.0±27.73 mm Hg to 8.7±6.5 mm Hg, p<0.001), and the SAM disappeared completely after the operation. Cardiac function was improved in all patients (New York Heart Association functional class III to class I/II).
Conclusions: The proposed optimal 3D-modelled septal myectomy allows intraoperative monitoring of the shape and volume of the myocardium resection to achieve the 'ideal' interventricular septum. It eliminates obstruction in the LVOT and SAM, resulting in LV remodeling with an increase in LV end-diastolic volume and diameter at early follow-up.
Keywords: 3D printing; Heart model; Hypertrophic cardiomyopathy; Myectomy.
Copyright: © Pakistan Journal of Medical Sciences.
Conflict of interest statement
Declaration of conflicting interest: The authors declare that there is no conflict of interest. Conflicts of interest: None.
Figures


Similar articles
-
Application of 3D printing in the surgical planning of hypertrophic obstructive cardiomyopathy and physician-patient communication: a preliminary study.J Thorac Dis. 2018 Feb;10(2):867-873. doi: 10.21037/jtd.2018.01.55. J Thorac Dis. 2018. PMID: 29607159 Free PMC article.
-
Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy.JTCVS Open. 2022 Jun 27;11:105-115. doi: 10.1016/j.xjon.2022.05.018. eCollection 2022 Sep. JTCVS Open. 2022. PMID: 36172435 Free PMC article.
-
Early results of optimal septal myectomy using 3-dimensional printed models.Kardiochir Torakochirurgia Pol. 2019 Jul;16(2):74-80. doi: 10.5114/kitp.2019.86359. Epub 2019 Jun 28. Kardiochir Torakochirurgia Pol. 2019. PMID: 31410094 Free PMC article.
-
Scan, plan, print, practice, perform: Development and use of a patient-specific 3-dimensional printed model in adult cardiac surgery.J Thorac Cardiovasc Surg. 2017 Jan;153(1):132-140. doi: 10.1016/j.jtcvs.2016.08.007. Epub 2016 Aug 20. J Thorac Cardiovasc Surg. 2017. PMID: 27650000
-
A systematic review and pooled analysis of septal myectomy and edge-to-edge mitral valve repair in obstructive hypertrophic cardiomyopathy.Rev Cardiovasc Med. 2021 Dec 22;22(4):1471-1477. doi: 10.31083/j.rcm2204151. Rev Cardiovasc Med. 2021. PMID: 34957786
Cited by
-
Three-Dimensional Heart Modeling of Hypertrophic Obstructive Cardiomyopathy for In Situ Patient-Specific Simulation to Optimize Septal Myectomy.Innovations (Phila). 2024 Sep-Oct;19(5):532-540. doi: 10.1177/15569845241273538. Epub 2024 Sep 2. Innovations (Phila). 2024. PMID: 39219341 Free PMC article.
-
Applications of 3D Printing Technology in Diagnosis and Management of Heart Failure.Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):271-277. doi: 10.1007/s11936-024-01045-3. Epub 2024 Jun 21. Curr Treat Options Cardiovasc Med. 2024. PMID: 40453755 Free PMC article.
-
Commentary: All models are wrong, but some are useful.JTCVS Tech. 2021 Mar 5;9:109-110. doi: 10.1016/j.xjtc.2021.03.010. eCollection 2021 Oct. JTCVS Tech. 2021. PMID: 34647076 Free PMC article. No abstract available.
-
An Implementation of Patient-Specific Biventricular Mechanics Simulations With a Deep Learning and Computational Pipeline.Front Physiol. 2021 Sep 16;12:716597. doi: 10.3389/fphys.2021.716597. eCollection 2021. Front Physiol. 2021. PMID: 34603077 Free PMC article.
References
-
- American College of Cardiology Foundation/American Heart Association Task Force on P, American Association for Thoracic S, American Society of E, American Society of Nuclear C, Heart Failure Society of A, Heart Rhythm S, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011;142(6):e153–203. doi:10.1016/j.jtcvs.2011.10.020. - PubMed
-
- Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, et al. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation. 2017;136(25):2420–2436. doi:10.1161/CIRCULATIONAHA.117.029267. - PubMed
-
- Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy:A Test in Context. J Am Coll Cardiol. 2016;67(15):1846–1858. doi:10.1016/j.jacc.2016.01.071. - PubMed
-
- Authors/Task Force m. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J. 2014;35(39):2733–2779. doi:10.1093/eurheartj/ehu284. - PubMed
-
- Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy:present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64(1):83–99. doi:10.1016/j.jacc.2014.05.003. - PubMed
LinkOut - more resources
Full Text Sources